Search by Drug Name or NDC

    NDC 42708-0036-30 Losartan Potassium and Hydrochlorothiazide 12.5; 50 mg/1; mg/1 Details

    Losartan Potassium and Hydrochlorothiazide 12.5; 50 mg/1; mg/1

    Losartan Potassium and Hydrochlorothiazide is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by QPharma Inc. The primary component is HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM.

    Product Information

    NDC 42708-0036
    Product ID 42708-036_f28b2cdd-7ca2-8ef2-e053-2a95a90ad9f1
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Losartan Potassium and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Losartan Potassium and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 12.5; 50
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
    Labeler Name QPharma Inc
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077157
    Listing Certified Through 2024-12-31

    Package

    NDC 42708-0036-30 (42708003630)

    NDC Package Code 42708-036-30
    Billing NDC 42708003630
    Package 30 TABLET, FILM COATED in 1 BOTTLE (42708-036-30)
    Marketing Start Date 2018-03-14
    NDC Exclude Flag N
    Pricing Information N/A